Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Return on Assets (2021 - 2025)

Xeris Biopharma Holdings filings provide 5 years of Return on Assets readings, the most recent being 0.0% for Q4 2025.

  • On a quarterly basis, Return on Assets changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Assets hit 0.0% in Q4 2025 for Xeris Biopharma Holdings, up from 0.0% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2025 to a low of 0.01% in Q4 2021.
  • Median Return on Assets over the past 5 years was 0.0% (2024), compared with a mean of 0.0%.
  • The widest YoY moves for Return on Assets: up 0bps in 2022, down 0bps in 2022.
  • Xeris Biopharma Holdings' Return on Assets stood at 0.01% in 2021, then skyrocketed by 48bps to 0.0% in 2022, then soared by 35bps to 0.0% in 2023, then rose by 11bps to 0.0% in 2024, then soared by 101bps to 0.0% in 2025.
  • The last three reported values for Return on Assets were 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.